StockWire X | ASX News (@StockWireX) header
StockWire X | ASX News (@StockWireX) profile picture

StockWire X | ASX News

@StockWireX

StockWire X is a digital investor publication dedicated exclusively to ASX-listed companies outside the mining sector.

 Australia
stockwirex.com
Joined November 2021
  • Tweets4.4K
  • Following1.4K
  • Followers20.8K
209Media
Photo by StockWire X | ASX News (@StockWireX)Photo by StockWire X | ASX News (@StockWireX)Photo by StockWire X | ASX News (@StockWireX)Photo by StockWire X | ASX News (@StockWireX)Photo by StockWire X | ASX News (@StockWireX)Photo by StockWire X | ASX News (@StockWireX)Photo by StockWire X | ASX News (@StockWireX)Photo by StockWire X | ASX News (@StockWireX)Photo by StockWire X | ASX News (@StockWireX)Photo by StockWire X | ASX News (@StockWireX)
$836K cash at quarter end as @evehealthgroup reports Q1 FY27 Libbo® pathway progress $EVE stockwirex.com/asx-stock-new…
EVE Health Targets Q4 2026 Pilot Dosing With $836,000 Cash

EVE Health Targets Q4 2026 Pilot Dosing With $836,000 Cash

EVE Health Group Ltd's quarterly update: Libbo oral film pathway live, pilot dosing set for Q4 2026. See what it means for investors.

stockwirex.com
62
Patients aged 12+ now eligible for Minder System after FDA clearance $EPI stockwirex.com/asx-stock-new…
Epiminder Expands Minder Clearance to US Patients Aged 12 and Older

Epiminder Expands Minder Clearance to US Patients Aged 12 and Older

Epiminder Ltd wins FDA clearance for its Minder System in ages 12+, opening a new adolescent epilepsy market. See what it means.

stockwirex.com
61
$6.4M customer receipts, up 29%, as @VectionTech posted Q1 FY27 cash report $VR1 stockwirex.com/asx-stock-new…
Vection Lifts Q1 FY27 Customer Receipts 29% as Operating Outflow Narrows

Vection Lifts Q1 FY27 Customer Receipts 29% as Operating Outflow Narrows

Vection Technologies Ltd's quarterly cash report shows receipts up 29% to $6.4M and outflow slashed to $0.2M. See the full results.

stockwirex.com
60
86% Cohort 3 ORR for azer-cel as @TeamImugene reported Q1 FY27 cash outflow down 19% $IMU stockwirex.com/asx-stock-new…
Imugene Azer-cel Posts 86% Response Rate in Early Cohort 3 Data

Imugene Azer-cel Posts 86% Response Rate in Early Cohort 3 Data

Imugene Ltd's azer-cel quarterly report shows 86% Cohort 3 response and cash outflow down 19%. Read what it means for investors.

stockwirex.com
1
78
91.40% of Kip McGrath shares held as Crimson Australia takeover offer closes 4 November $KME stockwirex.com/asx-stock-new…
Kip McGrath Stake Tops 91% as Crimson Plans Buyout of Rest

Kip McGrath Stake Tops 91% as Crimson Plans Buyout of Rest

Kip McGrath Crimson takeover offer passes 91.4%. Kip Mcgrath Education Centres Ltd faces compulsory acquisition. See what holdouts must do.

stockwirex.com
55
$74.3M work-in-hand recorded in Q1 FY27, up 395% on PCP as Synertec posted $5.9M revenue $SOP stockwirex.com/asx-stock-new…
Synertec Contracted Work Jumps 395% to $74.3M, Covering FY27 Guidance

Synertec Contracted Work Jumps 395% to $74.3M, Covering FY27 Guidance

Synertec Powerhouse FY27 quarterly update: Synertec Corporation Ltd reports $74.3M work-in-hand, up 395%. See what it means.

stockwirex.com
51
October billable minutes tracking 50% higher as Vitasora enters Treasure Coast contract $VHL stockwirex.com/asx-stock-new…
Vitasora Health Signs Florida Health Centre Deal Worth 9,000 Patients

Vitasora Health Signs Florida Health Centre Deal Worth 9,000 Patients

Vitasora Health Ltd signs Treasure Coast contract and A$3M facility, boosting growth. Read what it means for investors.

stockwirex.com
1
93
23.2% revenue lift to $52.1m recorded in Q1 FY27 alongside 30% Apiary stake $CUP stockwirex.com/asx-stock-new…
Count Lifts Q1 FY27 Revenue 23.2% and Underlying EBITA 66.6%

Count Lifts Q1 FY27 Revenue 23.2% and Underlying EBITA 66.6%

Count Ltd's Apiary equity partnership lands a 30% stake as Q1 revenue jumps 23.2% to $52.1M. See what it means for shareholders.

stockwirex.com
70
Revenue up ~70% to A$324M as @CivmecAU recorded Q1 FY27 growth on Wagerup Gallium win $CVL stockwirex.com/asx-stock-new…
Civmec Lifts Q1 FY27 Revenue ~70% as Order Book Reaches ~$1.4b

Civmec Lifts Q1 FY27 Revenue ~70% as Order Book Reaches ~$1.4b

Civmec Ltd wins the Wagerup Gallium Project as Q1 revenue surges 70% to A$324M and its order book hits A$1.4B. See what it means.

stockwirex.com
65
$50.0M contracted revenue, up 38%, as @alcidion lands $7.5M NCA Miya deal $ALC stockwirex.com/asx-stock-new…
Alcidion Lifts FY27 Contracted Revenue 38% to $50M Year to Date

Alcidion Lifts FY27 Contracted Revenue 38% to $50M Year to Date

Alcidion FY27 trading update: $50.0M contracted revenue, up 38% Alcidion Group (ASX:ALC) has released its FY27 year-to-date trading update, reporting contracted (sold and renewal) revenue of $50.0M...

stockwirex.com
1
108
A$1.62m Q3 2026 US revenue as Cyclopharm outlined 76% consumable sales $CYC stockwirex.com/asx-stock-new…
Cyclopharm Lifts Record Q3 US Sales as Consumable Orders Reach 76%

Cyclopharm Lifts Record Q3 US Sales as Consumable Orders Reach 76%

Cyclopharm Ltd posts record A$1.62m Q3 revenue, up 124%, as Technegas US growth surges. See how cash burn is falling.

stockwirex.com
1
1
110
$26.085M ACV and every location EBITDA profitable as Jcurve outlined its Q1 FY27 update $JCS stockwirex.com/asx-stock-new…
Jcurve Lifts Annual Contract Value to $26.1M in Q1 FY27

Jcurve Lifts Annual Contract Value to $26.1M in Q1 FY27

Jcurve Solutions Q1FY27 investor update reports ACV up to $26.085M with every location EBITDA profitable. See the AI growth plan.

stockwirex.com
73
$5M non-dilutive facility lines up working capital for @rocketboots_asx rollout $ROC stockwirex.com/asx-stock-new…
RocketBoots Arranges Up to $5M Facility for Global Rollout

RocketBoots Arranges Up to $5M Facility for Global Rollout

Rocketboots Ltd arranges up to $5M financing facility to fund its global rollout. See what it means for shareholders now.

stockwirex.com
88
Receipts up 15x to A$1.18M as @PIL_FinTech_Co P2M scaled in Q1 FY27 $PIL stockwirex.com/asx-stock-new…
Peppermint Lifts Q1 Receipts 15x as P2M Payments Scale Up

Peppermint Lifts Q1 Receipts 15x as P2M Payments Scale Up

Peppermint Innovation P2M Payments drive receipts up 15x to A$1.18M. See how Peppermint Innovation Ltd cut cash burn 55%. Read more.

stockwirex.com
1
1
156
Dr John Melki joins @GeneticSig board as BCAL challenges Microba merger split $GSS Visit stockwirex.com/asx-stock-new… for full details.
105
40/60 Microba split draws BCAL concerns as @GeneticSig adds Dr Melki to board $GSS stockwirex.com/asx-stock-new…
Genetic Signatures Adds Former CEO to Board as BCAL Questions Merger

Genetic Signatures Adds Former CEO to Board as BCAL Questions Merger

Dr John Melki appointed to GSS Board as BCAL voices merger concerns Shareholders approved Dr John Melki’s appointment to the Genetic Signatures Limited (ASX: GSS) Board at the Extraordinary General...

stockwirex.com
104
21.8% creatine category growth forecast as Elixinol Wellness launches Healthy Chef sachets $EXL stockwirex.com/asx-stock-new…
Elixinol Launches Creatine and Electrolyte Sachets for The Healthy Chef

Elixinol Launches Creatine and Electrolyte Sachets for The Healthy Chef

The Healthy Chef launches Creatine + Electrolytes range Elixinol Wellness Limited (ASX: EXL) has launched The Healthy Chef Creatine + Electrolytes, extending its nutrition range into a growing...

stockwirex.com
67
$5.45 cash per security: Warburg Pincus lifts Ingenia offer over AVID $INA stockwirex.com/asx-stock-new…
Ingenia Gets a $5.45 Cash Bid From Warburg as AVID Must Match

Ingenia Gets a $5.45 Cash Bid From Warburg as AVID Must Match

Ingenia Communities Group receives a higher Warburg Pincus proposal at $5.45 cash. Can AVID match it? See what happens next.

stockwirex.com
80
Turnover up 19.1% to $432.3M as betr recorded Q1 FY27 growth and reaffirmed guidance $BBT stockwirex.com/asx-stock-new…
betr Posts Q1 FY27 Turnover Up 19.1% as October Margin Rebounds So Far

betr Posts Q1 FY27 Turnover Up 19.1% as October Margin Rebounds So Far

Betr Entertainment Ltd (ASX:BBT) lifts Q1 FY27 turnover 19.1% to $432.3M and reaffirms guidance. Read more.

stockwirex.com
90
US$144k three-year Ensight deal with Arizona's SMIL marks @enlitic $ENL fifth US win stockwirex.com/asx-stock-new…
Enlitic Signs Fifth US Ensight Deal, but Fees Hinge on a 15% Gain

Enlitic Signs Fifth US Ensight Deal, but Fees Hinge on a 15% Gain

Enlitic Ensight Arizona contract adds US$144K in recurring revenue as Enlitic, Inc. signs Southwest Medical Imaging. See what it means.

stockwirex.com
54
Load more